Cargando…
Antitumour imidazotetrazines--XI: Effect of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one [CCRG 81045; M and B 39831 NSC 362856] on poly(ADP-ribose) metabolism.
Autor principal: | Tisdale, M. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1985
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977218/ https://www.ncbi.nlm.nih.gov/pubmed/3864485 |
Ejemplares similares
-
Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).
por: Newlands, E. S., et al.
Publicado: (1992) -
Antitumour imidazotetrazines: past, present… and future?
por: Stevens, Malcolm F. G., et al.
Publicado: (2023) -
Antitumour imidazotetrazines, Part IX. The pharmacokinetics of mitozolomide in mice.
por: Goddard, C., et al.
Publicado: (1985) -
Mechanistic
Insights into the Reaction of Amidines
with 1,2,3-Triazines and 1,2,3,5-Tetrazines
por: Wu, Zhi-Chen, et al.
Publicado: (2022) -
The Medicinal Chemistry of Imidazotetrazine Prodrugs
por: Moody, Catherine L., et al.
Publicado: (2014)